Xinxiang Shuanglu Pharmaceutical

Xinxiang Shuanglu Pharmaceutical is a Chinese pharmaceutical company primarily focused on the development, production, and sale of biochemical and genetic engineering drugs. As a key subsidiary of Beijing Shuanglu Pharmaceutical (SL PHARM), the company operates significant manufacturing facilities that adhere to GMP standards. Its product portfolio includes treatments for cardiovascular diseases, oncology, and hematology, with a strong emphasis on recombinant proteins and small molecule therapeutics. The company plays a vital role in the parent group's supply chain, handling large-scale production for both domestic and international markets. Xinxiang Shuanglu is recognized for its integration of research and industrialization within the Henan province biotech corridor.